ArticleScientific reports2025
Integrative severity scale for diabetic macular atrophy and ischemia using structural OCT and OCT angiography.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We investigated the characteristics of neurovascular degeneration in diabetic retinopathy (DR) using optical coherence tomography (OCT) and OCT angiography (OCTA). En-face 3 × 3 mm OCTA images were obtained from 327 eyes of DR patients without macular edema. Nonperfusion squares (NPSs) were defined as 15 × 15-pixel regions lacking vascular signals. Neurovascular parameters were extracted from five subfields of the Early Treatment Diabetic Retinopathy Study grid. High-dimensional data were embedded into a two-dimensional space using Uniform Manifold Approximation and Projection, and clustering revealed three distinct groups: Mild, Intermediate, and Severe. Eyes with central subfield thickness (CST) < 246 μm were classified as having diabetic macular atrophy. The Mild group exhibited lower NPS counts, while the Intermediate group showed increased NPS counts in the deep layer. The Severe group had the highest NPS counts and the lowest CST, with a significant negative correlation between CST and superficial NPS counts (ρ = - 0.252, P = 0.039). Eyes with diabetic macular atrophy in the Severe group demonstrated higher NPS counts, worse visual acuity, and more frequent ellipsoid zone disruption compared to the Mild and Intermediate groups (P < 0.001). These findings suggest a pathological relationship between macular ischemia and retinal atrophy, offering new insights into DR progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.